查詢結果分析
相關文獻
- Quantitative Assessment of Efficacy of Dysport (Botulinum Toxin Type A) in the Treatment of Idiopathic Blepharospasm and Hemifacial Spasm
- Use of Botulinum Toxin A in the Treatment of Hemifacial Spasm and Blepharospasm
- 顱顏肌肉的不自主運動:雙側眼瞼痙攣與半邊顏面痙攣
- 肉毒桿菌素在眼科醫療領域的應用
- 燻煙及亞硝酸鈉對常溫貯藏去皮雞腿製品化學特性及肉毒桿菌毒素之影響
- 肉毒桿菌產毒預測模式應用在冷藏真空調理食品安全評估
- Botulinum Toxin Type A: From Toxin to Therapeutic Agent
- Use of Hurdle Technology to Extend Shelf-life of Pressed Ham
- Treatment of Cerebral Palsy with Botulinum Toxin: Evaluation with Gross Motor Function Measure
- 以毒攻皺﹖--訪臺大醫院皮膚科臨床教授吳英俊
頁籤選單縮合
題 名 | Quantitative Assessment of Efficacy of Dysport (Botulinum Toxin Type A) in the Treatment of Idiopathic Blepharospasm and Hemifacial Spasm=以肉毒桿菌素治療眼瞼痙攣及半邊臉痙攣的量化評估 |
---|---|
作 者 | 蔡清標; 邱銘章; 顏得楨; 郭育呈; 袁志倫; 李子奇; | 書刊名 | Acta Neurologica Taiwanica |
卷 期 | 14:2 2005.06[民94.06] |
頁 次 | 頁61-68 |
分類號 | 415.83 |
關鍵詞 | 肉毒桿菌; 眼瞼痙攣; 半邊臉痙攣; Dysport; Efficacy; Blepharospasm; Hemifacial spasm; |
語 文 | 英文(English) |
英文摘要 | This study was a Phase IV, prospective, one arm, non-comparative open trial, to investigate the efficacy and safety of Dysport (Botulinum toxin type A) in patients with idiopathic blepharo spasm or hemi-facial spasm. During the treatment period, patients were evaluated at baseline (week 0), week 6, and week 8, 10, or 12. Thirty two women and 16 men completed the whole course of the study. The therapeutic efficacy of Dysport became evident from 1.5 to 15 days (mean ±SD, 6.1±2.9 days). The maximal effect appeared 12.2 ±5.0 days later. Injection of Dysport achieved 72.9 (13.0% amelioration in the spasm symptom. Dysport significantly improved the following functions, such as reading, watching TV house work, working, driving and outing alone. At the twelfth week after Dysport injection, it was still effective in relieving blepharospasm or hemifacial spasm. The most frequent adverse event was ptosis, which was noted in 9 cases and represented 18.7% of total patients. Other adverse events were very mild, although lagophthalmos and dry eyes occurred in some patients, but none manifested any corneal complications. In conclusion, Dysport injection appears to be a safe, and effective procedure-accompanied only by minor, and transit adverse events. |
本系統中英文摘要資訊取自各篇刊載內容。